156 related articles for article (PubMed ID: 11042692)
1. Interferon-beta induces S phase slowing via up-regulated expression of PML in squamous carcinoma cells.
Vannucchi S; Percario ZA; Chiantore MV; Matarrese P; Chelbi-Alix MK; Fagioli M; Pelicci PG; Malorni W; Fiorucci G; Romeo G; Affabris E
Oncogene; 2000 Oct; 19(44):5041-53. PubMed ID: 11042692
[TBL] [Abstract][Full Text] [Related]
2. Interferon alpha-2b and retinoic acid combined treatment affects proliferation and gene expression of human cervical carcinoma cells.
Lancillotti F; Giandomenico V; Affabris E; Fiorucci G; Romeo G; Rossi GB
Cancer Res; 1995 Jul; 55(14):3158-64. PubMed ID: 7606736
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis and growth inhibition of squamous carcinoma cells treated with interferon-alpha, IFN-beta and retinoic acid are associated with induction of the cyclin-dependent kinase inhibitor p21.
Giandomenico V; Vaccari G; Fiorucci G; Percario Z; Vannuchi S; Matarrese P; Malorni W; Romeo G; Affabris GR
Eur Cytokine Netw; 1998 Dec; 9(4):619-31. PubMed ID: 9889406
[TBL] [Abstract][Full Text] [Related]
4. Promyelocytic leukemia protein-induced growth suppression and cell death in liver cancer cells.
Son SH; Yu E; Choi EK; Lee H; Choi J
Cancer Gene Ther; 2005 Jan; 12(1):1-11. PubMed ID: 15529177
[TBL] [Abstract][Full Text] [Related]
5. All-trans, 13-cis and 9-cis retinoic acids induce a fully reversible growth inhibition in HNSCC cell lines: implications for in vivo retinoic acid use.
Giannini F; Maestro R; Vukosavljevic T; Pomponi F; Boiocchi M
Int J Cancer; 1997 Jan; 70(2):194-200. PubMed ID: 9009160
[TBL] [Abstract][Full Text] [Related]
6. E1A-mediated suppression of EGFR expression and induction of apoptosis in head and neck squamous carcinoma cell lines.
Flinterman M; Gäken J; Farzaneh F; Tavassoli M
Oncogene; 2003 Apr; 22(13):1965-77. PubMed ID: 12673202
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative effects of retinoic acid/interferon in cervical carcinoma cell lines: cooperative growth suppression of IRF-1 and p53.
Um SJ; Kim EJ; Hwang ES; Kim SJ; Namkoong SE; Park JS
Int J Cancer; 2000 Feb; 85(3):416-23. PubMed ID: 10652435
[TBL] [Abstract][Full Text] [Related]
8. PML/RAR alpha+ U937 mutant and NB4 cell lines: retinoic acid restores the monocytic differentiation response to vitamin D3.
Testa U; Grignani F; Barberi T; Fagioli M; Masciulli R; Ferrucci PF; Seripa D; Camagna A; Alcalay M; Pelicci PG
Cancer Res; 1994 Aug; 54(16):4508-15. PubMed ID: 7519122
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid and IFN inhibition of cell proliferation is associated with apoptosis in squamous carcinoma cell lines: role of IRF-1 and TGase II-dependent pathways.
Giandomenico V; Lancillotti F; Fiorucci G; Percario ZA; Rivabene R; Malorni W; Affabris E; Romeo G
Cell Growth Differ; 1997 Jan; 8(1):91-100. PubMed ID: 8993838
[TBL] [Abstract][Full Text] [Related]
10. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
[TBL] [Abstract][Full Text] [Related]
11. Induction of the pro-myelocytic leukaemia gene by type I and type II interferons.
Heuser M; van der Kuip H; Falini B; Peschel C; Huber C; Fischer T
Mediators Inflamm; 1998; 7(5):319-25. PubMed ID: 9883966
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid and interferon-alpha effects on cell growth and differentiation in cervical carcinoma cell lines.
Yokoyama M; Nakao Y; Iwasaka T; Pater A; Sugimori H
Obstet Gynecol; 2001 Aug; 98(2):332-40. PubMed ID: 11506854
[TBL] [Abstract][Full Text] [Related]
13. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins.
Zhong S; Delva L; Rachez C; Cenciarelli C; Gandini D; Zhang H; Kalantry S; Freedman LP; Pandolfi PP
Nat Genet; 1999 Nov; 23(3):287-95. PubMed ID: 10610177
[TBL] [Abstract][Full Text] [Related]
14. Interferon-alpha and all-trans-retinoic acid reversibly inhibit the in vitro proliferation of cell lines derived from cervical cancers.
Massad LS; Turyk ME; Bitterman P; Wilbanks GD
Gynecol Oncol; 1996 Mar; 60(3):428-34. PubMed ID: 8774652
[TBL] [Abstract][Full Text] [Related]
15. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.
He LZ; Guidez F; Tribioli C; Peruzzi D; Ruthardt M; Zelent A; Pandolfi PP
Nat Genet; 1998 Feb; 18(2):126-35. PubMed ID: 9462740
[TBL] [Abstract][Full Text] [Related]
16. The antiproliferative effect of trans-retinoic acid is associated with selective induction of interleukin-1 beta, a cytokine that directly inhibits growth of lung cancer cells.
Ross HJ
Oncol Res; 1996; 8(4):171-8. PubMed ID: 8869967
[TBL] [Abstract][Full Text] [Related]
17. All-trans-retinoic acid blocks cell cycle progression of human ovarian adenocarcinoma cells at late G1.
Wu S; Donigan A; Platsoucas CD; Jung W; Soprano DR; Soprano KJ
Exp Cell Res; 1997 May; 232(2):277-86. PubMed ID: 9168803
[TBL] [Abstract][Full Text] [Related]
18. Restoration of promyelocytic leukemia protein-nuclear bodies in neuroblastoma cells enhances retinoic acid responsiveness.
Yu JH; Nakajima A; Nakajima H; Diller LR; Bloch KD; Bloch DB
Cancer Res; 2004 Feb; 64(3):928-33. PubMed ID: 14871822
[TBL] [Abstract][Full Text] [Related]
19. Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis.
Le XF; Vallian S; Mu ZM; Hung MC; Chang KS
Oncogene; 1998 Apr; 16(14):1839-49. PubMed ID: 9583681
[TBL] [Abstract][Full Text] [Related]
20. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E
Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
